Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses.
710 Medtronic Pkwy
Minneapolis, MN 55432-5604
News | Heart Valve Technology | April 20, 2017
The Structural Heart Program at Princeton Baptist Medical Center, (Birmingham, Ala.) recently became the first center...
News | Atrial Fibrillation | April 11, 2017
April 10, 2017 — Medtronic recently announced the first enrollments in the STOP Persistent AF clinical trial.
Feature | Heart Valve Technology | March 22, 2017
March 22, 2017 – The U.S.
News | Heart Valve Technology | March 17, 2017 | Dave Fornell
March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve r
Technology | Implantable Cardiac Monitor (ICM) | March 15, 2017
Medtronic Receives FDA Clearance for Reveal LINQ Insertable Cardiac Monitor With TruRhythm Detection
Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Reveal LINQ Insertable Cardiac...
News | Implantable Cardiac Monitor (ICM) | March 14, 2017
Climbing above 4,000 meters can provoke abnormal heart rhythms in otherwise healthy mountaineers, with the...
Technology | Heart Valve Technology | March 14, 2017
March 14, 2017 — The United States Food and Drug Administration (FDA) has expanded use of the Medtronic Melody Transc
News | Pacemakers | March 10, 2017
March, 10, 2017 - Medtronic announced that the U.S.
News | Peripheral Artery Disease (PAD) | March 09, 2017
Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a drug-coated balloon (DCB...
News | Cardiac Resynchronization Therapy Devices (CRT) | March 07, 2017
March 7, 2017 — Medtronic plc recently announced an economic analysis of five-year data showing that patients with mi